CROI 2024 Abstract eBook

Abstract eBook

Disclosure Index

DISCLOSURE OF FINANCIAL RELATIONSHIPS WITH INELIGIBLE COMPANIES In the interest of maintaining the independence of its continuing medical education (CME) activities, the International Antiviral Society–USA (IAS– USA) requires all persons with control of educational content (eg, the Scientific Program Committee, Community Liaison Subcommittee, invited speakers, and program staff) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved and mitigated prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in IAS–USA CME activities. The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” This information is intended to make the audience aware of speaker and contributor financial relationships with ineligible companies, enabling the audience members to form their own judgments about such associations. Each author, contributor, or person in control of the content in the CME activity is required to complete this financial disclosure declaration. In accordance with IAS–USA policy, the IAS–USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Information about financial relationships with ineligible companies for the presenters and planners/reviewers will also be available in the slides prior to the presentation of educational content.

Disclosure Information

https://www.croiconference.org/wp-content/uploads/sites/2/resources/2024/croi2024-disclosure-information.pdf

CROI 2024 414